Arrhythmia detection and monitoring are evolving rapidly, reshaping how cardiac electrophysiology (EP) teams identify, track, and manage rhythm disorders across the care continuum. Advances in artificial intelligence (AI), wearable and implantable technologies, and remote data integration are expanding diagnostic reach beyond the traditional EP lab—while introducing new workflow, data, and interpretation challenges for clinicians and device specialists.

Wearable technologies have rapidly evolved from consumer wellness tools into clinically relevant instruments for arrhythmia detection, particularly atrial fibrillation (AF). For cardiologists and electrophysiology (EP) teams, modern wearables now offer scalable options for screening, continuous rhythm monitoring, and earlier diagnosis across diverse patient populations.

In atrial fibrillation (AF), common modifiable conditions contribute to atrial remodeling and create a substrate for recurrent arrhythmia. Recent literature and guideline-aligned care pathways increasingly emphasize lifestyle and comorbidity management alongside rate/rhythm control.¹ This article highlights key modifiable risk factors and practical tools—targeting obesity, hypertension, sleep apnea, physical inactivity, diabetes, alcohol use, and tobacco exposure—to improve outcomes in AF.

What does “prevention” mean in contemporary AF management?
Atrial fibrillation (AF) prevention includes primary prevention (reducing incident AF through upstream risk factor modification) and secondary prevention (slowing AF progression, reducing recurrence and burden, and preventing AF-related adverse outcomes). Current US and European guidelines characterize AF as a staged, progressive disease, supporting early, longitudinal intervention.¹,²

FAQ 1. What is pulsed field ablation (PFA), and how does it work?